http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012268829-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57572c5235bf996df83df9c29ff8779d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e373a9599e5dfff76e80545326008b76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98ebcd56f2a4a17c929dbe0704ba41df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d358aabe68e388ebd92da015ec59193 |
| publicationDate | 2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2012268829-A1 |
| titleOfInvention | Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| abstract | C:\NRPortbI\DCC\REC\4831309 _.DOC-12/21/2012 The present invention relates to enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)- 4 -oxo-4H-pyrido[1,2-a]pyrimidin-9 yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase B and use of the selective inhibitor in e.g. anti-thrombotic therapy. |
| priorityDate | 2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.